Dynamic Changes of Serum HBV RNA in Chronic Hepatitis B Patients

计划入组 100 人 · 首次发布于 2023 年 8 月 14 日

Serum HBV RNA Value on Chronic Hepatitis B Virus Infection Manage

计划入组 454 人 · 首次发布于 2019 年 4 月 9 日

Sequential PEG-IFN for HBV After Ending RNA-targeted Regimens

计划入组 72 人 · 首次发布于 2025 年 4 月 11 日

HBV RNA destabilizer(zhimeng Biopharma)

HBV

HBV-002

Rna Diagnostics, Inc.

Canada

RNA Pharma, LLC

United States

BioNTech RNA Pharmaceuticals GmbH

Germany

Arbutus Biopharma to Present Promising Imdusiran and AB-101 Data for Chronic Hepatitis B at EASL Congress 2025

Assembly Bio's ABI-4334 Shows Promise in Phase 1b Trial for Chronic Hepatitis B

Tune Therapeutics' TUNE-401, a First-in-Class Epigenetic Silencer, Enters Clinical Trials for Chronic Hepatitis B